U

UCB BIOPHARMA (Private limited company)

UCB Biopharma
BE 0543.573.053 Active ●Allée de la Recherche 60, 1070 Anderlecht

UCB BIOPHARMA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0543.573.053. It was founded on 24-12-2013. Its registered office is in Anderlecht. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 1 175 020 354 and a profit of € 113 811 131. These accounts report 1395.2 full-time equivalents. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 09-10-2026.

Company information

Status
Active
Enterprise number
BE 0543.573.053
VAT registered
Yes
Founded
24-12-2013
Latest accounts
2025
Employees
1395.2 FTE
Region
Brussels-Capital
Establishments
3
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Allée de la Recherche 60, 1070 Anderlecht
Main activity
Scientific research and development
NACE activities
72101 Recherche-développement en biotechnologie
21201 Fabrication de médicaments

Key figures of UCB BIOPHARMA

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 113 811 131+1 245 %€ 8 462 666€ -676 933 225-30 %€ -519 501 153
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 1 175 020 354+7 %€ 1 101 860 673+276 %€ 293 398 007-70 %€ 970 331 232
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 7 153 115 798+15 %€ 6 244 745 945+22 %€ 5 133 880 523-3 %€ 5 305 267 743
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
----
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
1395.2+6 %1317.9+4 %1269.40 %1267.9

Financial estimate

Financial health grade B, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
6 mandates on record in the annual accounts. 1 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Anderlecht.

CompanyTown
KERRY INGREDIENTS BELGIUM 1070 Anderlecht
CEGEDIM BELGIUM 1070 Anderlecht
FYTEKO 1070 Anderlecht
SERVIER R & D BENELUX 1070 Anderlecht
SHANT HOLDING 1070 Anderlecht
INNOVATIVE MICROBIAL BIOPROCESS 1070 Anderlecht
LABORATOIRES FILL-MED MANUFACTURING 1070 Anderlecht
FABULOUS 1070 Anderlecht
Looking for more information about UCB BIOPHARMA?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is UCB BIOPHARMA still active? Yes. The Crossroads Bank for Enterprises lists UCB BIOPHARMA as active.

What is the VAT number of UCB BIOPHARMA? The VAT number of UCB BIOPHARMA is BE 0543.573.053.

When was UCB BIOPHARMA founded? UCB BIOPHARMA was founded on 24-12-2013.

What is the address of UCB BIOPHARMA? The current registered office of UCB BIOPHARMA is Allée de la Recherche 60, 1070 Anderlecht.

When did UCB BIOPHARMA last file annual accounts? The latest annual accounts of UCB BIOPHARMA were filed on 23-07-2026.

Does UCB BIOPHARMA file its annual accounts on time? Yes. UCB BIOPHARMA filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does UCB BIOPHARMA have? UCB BIOPHARMA employs 1395.2 full-time equivalents according to its most recent annual accounts.

Is UCB BIOPHARMA financially healthy? Addrly gives UCB BIOPHARMA a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is UCB BIOPHARMA profitable? The annual accounts of UCB BIOPHARMA for 2025 show a profit of € 113 811 131.

What is the equity of UCB BIOPHARMA? The equity of UCB BIOPHARMA was € 1 175 020 354 at the close of the 2025 financial year.

Who are the directors of UCB BIOPHARMA? The annual accounts of UCB BIOPHARMA record 6 mandates. The names, roles and dates are visible with a free account.

Can UCB BIOPHARMA receive Peppol e-invoices? Yes. UCB BIOPHARMA is registered on the Peppol network and can receive structured electronic invoices.

What does UCB BIOPHARMA do? The main activity of UCB BIOPHARMA is: Scientific research and development.

Sources

How Addrly builds and refreshes this data